- E-mailaugust.bakke@uib.no
- Visitor AddressHaukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst5009 Bergen
- Postal AddressPostboks 78045020 Bergen
Academic article
- (2016). Preventing Complications - The Preflight Checklist. European Urology Focus. 60-62.
- (2016). Development of a disease-specific health-related quality of life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in renal cell carcinoma patients. Acta Oncologica. 349-356.
- (2015). Health-related quality of life, personality and choice of coping are related in renal cell carcinoma patients. Scandinavian Journal of Urology. 282-289.
- (2010). Voiding disorders among children and adolescents: surveillance after voiding school treatment. International Journal of Urological Nursing. 22-32.
- (2010). Pad per day usage, urinary incontinence and urinary tract infections in nursing home residents. Age and Ageing. 549-554.
- (2008). Residual urine as a risk factor for lower urinary tract infection: A 1-year follow-up study in nursing homes. Journal of The American Geriatrics Society. 871-874.
- (2008). Dynamic contrast enhanced magnetic resonance imaging of bladder cancer and implications for biological image-adapted radiotherapy. Acta Oncologica. 1257-1264.
- (2007). Renal cell carcinoma: A clinicopathological follow-up study after radical nephrectomy. Scandinavian Journal of Urology and Nephrology. 191-197.
- (2007). Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. Multiple Sclerosis. 106-112.
- (2007). Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. Multiple Sclerosis. 106-112.
- (2006). Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study. BJU International. 698-702.
- (2006). A concomitant tumour boost in bladder irradiation: Patient suitability and the potential of intensity-modulated radiotherapy. Radiotherapy and Oncology. 98-105.
- (2005). Gene expression profiles in prostate cancer: Association with patient subgroups and tumour differentiation. International Journal of Oncology. 329-336.
- (2004). The Potentially Curable Prostate Cancer Patient and the Pathways Leading to Diagnosis and Treatment. Scandinavian Journal of Urology and Nephrology. 15-18.
- (2004). Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia. International Journal of Radiation Oncology, Biology, Physics. 476-482.
- (2001). Vannlatingsproblemer og urinveiskomplikasjoner hos ungdom og voksne med myelomeningocele. Tidsskrift for Den norske legeforening. 1211-5.
- (2001). Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Multiple Sclerosis. 231-235.
- (2001). Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Multiple Sclerosis. 231-235.
- (2001). Reduced quality of life among MS patients with sexual disturbance and bladder dysfunction. Multiple Sclerosis. 231-235.
- (2001). Reduced quality of life among MS patients with sexual disturbance and bladder dysfunction. Multiple Sclerosis. 231-235.
- (2001). Reconstructive urology in the nordic countries - a hospital questionnaire survey. Scandinavian Journal of Urology and Nephrology. 186-9.
- (2001). Oppfølgning av urinveisproblemer hos voksne med myelomeningocele. Tidsskrift for Den norske legeforening. 1247-51.
- (1998). Psychological predictors of symptoms of urinary tract infection and bacteriuria in patients treated with clean intermittent catheterization. European Urology. 30-36.
- (1997). Utredning og oppfølgning ved BPH. Nytt om legemidler forts. av: Nytt fra Statens legemiddelkontroll. 19-20.
- (1997). Physical predictors of infection in patients treated with clean intermittent catheterization: a prospective 7-year study. British Journal of Urology. 85-90.
- (1997). Physical predictors of infection in patients treated with clean intermittent catheterization: a prospective 7-year study. British Journal of Urology. 85-90.
- (1997). Perforation of continent urinary reservoirs - Scandinavian experience. Scandinavian Journal of Urology and Nephrology. 529-532.
- (1997). Inhibition of mitogen-induced lymphoproliferation by soluble annexin II in sera from patients with renal carcinoma. APMIS - Journal of Pathologiy, Microbiology and Immunology. 699-704.
- (1996). Urinveisinfeksjon hos pasienter behandlet med selvkateterisering. En prevalensundersøkelse av pasienter på langtids ren intermitterende kateterisering. Tidsskrift for Den norske legeforening. 2552-2555.
- (1996). Urinveisinfeksjon hos pasienter behandlet med selvkateterisering. En prevalens undersøkelse av pasienter på langtids ren intermitterende kateterisering. Tidsskrift for Den norske legeforening. 2552-2555.
- (1996). Tamsulosin, the First Prostate-Selective _a1A-Adrenoceptor Antagonist. Analysis of a multinational, multicentre, open-label study assessing the long-term efficacy and safety in patients with benign prostatic Obstruction (Symptomatic BPH). European Urology. 145-154.
- (1996). Tamsulosin, the First Prostate-Selective _a1A-Adrenoceptor Antagonist. A Meta-analysis of two randomized placebo-controlled, multicentre studies in patients with benign prostatic obstruction (Symptomatic BPH). European Urology. 155-167.
- (1996). Bladder, bowel and sexual dysfunction in patients with multiple sclerosis - a cohort study. Scandinavian Journal of Urology and Nephrology. 61-66.
- (1996). Bladder, bowel and sexual dysfunction in patients with multiple sclerosis - a cohort study. Scandinavian Journal of Urology and Nephrology. 61-66.
- (1995). Ureteroscopy in pregnancy. Journal of Urology. 1660-1663.
- (1994). Psychosocial adjustment to illness scale (PAIS-SR) in a Norwegian material of patients with functional dyspepsia, duodenal ulcer, and urinary bladder dysfunction. Scandinavian Journal of Gastroenterology. 611-617.
- (1994). Normalisering av blæretømmingen hos pasienter på ren intermitterende katerisering. Nordisk Medicin. 56-57.
- (1994). Clean intermittent catheterization in lower urinary tract dysfunction - an overview. Scandinavian Journal of Urology and Nephrology. 55-60.
- (1993). Social functioning and general well-being in patients treated with clean intermittent catheterization. Journal of Psychosomatic Research. 371-380.
- (1993). Risk factors for bacteriuria and clinical urinary tract infection in patients treated with clean intermittent catheterization. Journal of Urology. 527-531.
- (1993). Risk factors for bacteriuria and clinical urinary tract infection in patients treated with clean intermittent catheterization. Journal of Urology. 527-531.
- (1993). Risk factors for bacteriuria and clinical urinary tract infection in patients treated with clean intermittent catheterization. Journal of Urology. 527-531.
- (1993). Risk factors for bacteriuria and clinical urinary tract infection in patients treated with clean intermittent catherisation. Journal of Urology. 527-531.
- (1993). Physical complications in patients treated with clean intermittent catheterization. Scandinavian Journal of Urology and Nephrology. 55-61.
- (1993). Physical complications in patients treated with clean intermittent catheterization. Scandinavian Journal of Urology and Nephrology. 55-61.
- (1993). Physical complications in patients treated with clean intermittent catheterization. Scandinavian Journal of Urology and Nephrology. 55-61.
- (1993). Physical complications in patients treated with clean intermittent catheterisation. Scandinavian Journal of Urology and Nephrology. 55-61.
- (1993). Clean intermittent catheterization. Physical and psychological complications. J Urol Nephrol. Suppl. 1-69.
- (1993). Clean intermittent catheterization-performing abilities, aversive experiences and distress. Paraplegia. 288-297.
- (1993). Clean intermittent catheterization - performing abilities, aversive experiences and distress. International Medical Society of Paraplegia. 288-297.
- (1993). Clean intermittent catheterisation - performing abilities, aversive experiences and distress. Paraplegia. 288-297.
- (1992). What is the requirement of clean intermittent catheterization? - An epidemiologic study. Neurourology and Urodynamics. 414-415.
- (1992). Physical complications and their risk factors in patients treated with clean intermittent catheterization. Neurourology and Urodynamics. 412-413.
- (1992). Incidence of improvement of bladder emptying in 1702 patients on clean intermittent catheterization. Neurourology and Urodynamics. 411-412.
- (1992). Clinical background of patients treated with cleanintermittent catherization in Norway. Scandinavian Journal of Urology and Nephrology. 211-217.
- (1992). Clinical background of patients treated with clean intermittent catheterization in Norway. Scandinavian Journal of Urology and Nephrology. 211-217.
- (1992). Clinical background of patients treated with clean intermittent catherization in Norway. Scandinavian Journal of Urology and Nephrology. 211-217.
- (1991). Urinary tract infection in patients treated with clean intermittent catheterization - predictive variables. Scandinavian Journal of Urology and Nephrology. 76-77.
- (1991). Quality of life and discomfort in patients with clean intermittent catheterization. Neurourology and Urodynamics. 305-306.
- (1991). Clinical background of patients treated with clean intermittent catheterization in Norway. Scandinavian Journal of Urology and Nephrology.
- (1991). Bacteriuria in patients treated with clean intermittent catheterization. Scandinavian Journal of Infectious Diseases. 577-582.
- (1991). Bacteriuria in patients treated with clean intermittent catheterization. Scandinavian Journal of Infectious Diseases. 577-582.
- (1991). Bacteriuria in patients treated with clean intermittent catheterization. Scandinavian Journal of Infectious Diseases. 577-582.
- (1985). Screening for hematuria, glucosuria and proteinuria in people aged 55-64. Scandinavian Journal of Primary Health Care. 31-34.
Academic lecture
- (2005). A concomitant tumour boost in bladder irradiation: Patient suitability and the potensial of intensity-modulated radiotherapy.
- (2004). Gene expression profiling in prostate cancer refined by pairwise comparisons of cDNA microarrays from benign and malignant tissue.
- (2003). Global analysis of gene expression and regulatory patterns in urogenital tumours using DNA microarrays.
- (2003). Global analysis of gene expression and regulatory patterns in cancer.
- (2003). Gene expression profiling in prostate cancer: Cluster analysis and association with tumor differentiation.
- (2003). Gene expression profiling in prostate cancer.
- (2003). DNA microarray studies of human cancer - pitfalls and outlook.
- (2003). Comparison of DNA microarray and real time quantitative PCR for quantitation of gene expression of selected genes in prostate cancer.
- (2002). Genital selvmutilering (GSM) - ren skjær galskap eller .. ?
- (2000). Survival after radical nephrectomy for renal cell carcinoma in 103 patients.
Editorial
- (2020). Når barn ikke får kontroll med vannlatingen. Tidsskrift for Den norske legeforening. 1-2.
Masters thesis
- (2008). Uroterapi til barn og unge -hvor står vi ? -hvor går vi?
Doctoral dissertation
- (2015). Time relations of biological markers in urothelial carcinomas.
- (2015). Health-related Quality of Life, Distress and Psychosocial Factors in Head and Neck and Renal Cancer Patients. Quality of Life in HNSCC and RCC patients.
- (1992). Clean intermittent catheterization - physical and psychological complications.
Academic chapter/article/Conference paper
- (1997). Treatment of BPH - the primary evaluation and follow-up procedures.
- (1991). Urinveisforstyrrelser. 15 pages.
Abstract
- (2009). Residual Urine as a Risk Factor for Lower Urinary Tract Infection: A 1-Year Follow-Up Study in Nursing Homes. Journal of Urology. 1139-1139.
Poster
- (2003). Gene expression profiling in prostate cancer refined by pairwise comparisons of cDNA microarrays from benign and malignant tissue.
More information in national current research information system (CRIStin)